| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. | J Am Coll Cardiol | 2005 | 1.01 |
| 2 | Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. | Qual Life Res | 2010 | 0.95 |